BUSINESS CONTINUITY & OPERATIONAL RESILIENCE

Bioscience Equity Partners maintains a formal, documented Business Continuity and Operational Resilience framework designed to ensure the orderly continuation of its advisory, capital markets, and discretionary fund management activities in the event of operational disruption.

The firm operates on a geographically distributed model across Europe, the British Virgin Islands, the Middle East, the United Kingdom, the United States, and Australia. No critical business activity is dependent on a single office, jurisdiction, system, or individual.

Business continuity arrangements are aligned with internationally recognised standards applicable to financial-services institutions and are integrated into the firm’s governance and risk management framework. Defined recovery objectives are maintained for critical communications, client servicing, documentation workflows, and access to data and systems.

Continuity planning includes centralised incident governance, secure and access-controlled digital infrastructure, cross-jurisdictional operational capability, oversight of critical third-party service providers, and controlled internal and external communications during disruptive events.

The firm reviews and tests its continuity arrangements periodically and updates them as required to reflect organisational, regulatory, and technological developments.

Bioscience Equity Partners regards operational resilience as a core institutional obligation and a prerequisite for engagement with sovereign investors, pension funds, regulated institutions, and other long-term capital providers.

Further information regarding business continuity arrangements may be made available to institutional counterparties and regulators upon request and subject to appropriate confidentiality protections.